RA
TMCI icon

RiverPark Advisors’s Treace Medical Concepts TMCI Stock Holding History

RiverPark Advisors’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,993
Closed -$117K – 143
2024
Q1 		$117K Buy
8,993
+7,952
+764% +$106K 0.1% 97
2023
Q4 		$13.3K Sell
1,041
-147
-12% -$1.49K 0.01% 104
2023
Q3 		$15.6K Buy
+1,188
New +$21.7K 0.01% 99

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RiverPark Advisors's TMCI Position: Q2 2024 in Review

RiverPark Advisors sold out of Treace Medical Concepts (TMCI) in Q2 2024, closing a stake of 8,993 shares — an estimated $117K sold.

RiverPark Advisors first reported a position in TMCI in Q3 2023 and held it in 3 quarters. The position peaked at $117K in Q1 2024. 127 funds tracked by Wall St. Rank hold TMCI as of Q2 2024.

  • RiverPark Advisors reported no remaining Treace Medical Concepts position as of Q2 2024 after selling out during the quarter.
  • RiverPark Advisors sold 8,993 Treace Medical Concepts shares in Q2 2024, an estimated $117K.
  • RiverPark Advisors first reported a position in Treace Medical Concepts in Q3 2023 and held it in 3 quarters.
  • RiverPark Advisors's Treace Medical Concepts position peaked at $117K in Q1 2024.
  • 127 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2024.

Based on RiverPark Advisors's 13F filing for Q2 2024, filed 26 Jul 2024.